128 related articles for article (PubMed ID: 32737220)
1. The lncRNA
Gong A; Zhao X; Pan Y; Qi Y; Li S; Huang Y; Guo Y; Qi X; Zheng W; Jia L
J Cell Sci; 2020 Aug; 133(16):. PubMed ID: 32737220
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA MEG3 induces renal cell carcinoma cells apoptosis by activating the mitochondrial pathway.
Wang M; Huang T; Luo G; Huang C; Xiao XY; Wang L; Jiang GS; Zeng FQ
J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):541-545. PubMed ID: 26223924
[TBL] [Abstract][Full Text] [Related]
3. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA MEG3 inhibits cell growth of gliomas by targeting miR-93 and inactivating PI3K/AKT pathway.
Zhang L; Liang X; Li Y
Oncol Rep; 2017 Oct; 38(4):2408-2416. PubMed ID: 28791407
[TBL] [Abstract][Full Text] [Related]
5. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.
Wang L; Yu M; Zhao S
J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607
[TBL] [Abstract][Full Text] [Related]
6. Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma.
Li M; Liu G; Jin X; Guo H; Setrerrahmane S; Xu X; Li T; Lin Y; Xu H
Mol Cancer; 2022 Sep; 21(1):181. PubMed ID: 36117171
[TBL] [Abstract][Full Text] [Related]
7. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.
Li Z; Ma Z; Xu X
Oncol Rep; 2019 Feb; 41(2):1113-1121. PubMed ID: 30431104
[TBL] [Abstract][Full Text] [Related]
8. MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1.
Sun Y; Cao FL; Qu LL; Wang ZM; Liu XY
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1459-1467. PubMed ID: 30840267
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MEG3 inhibit endometrial carcinoma tumorigenesis and progression through PI3K pathway.
Sun KX; Wu DD; Chen S; Zhao Y; Zong ZH
Apoptosis; 2017 Dec; 22(12):1543-1552. PubMed ID: 29094270
[TBL] [Abstract][Full Text] [Related]
10. lncRNA ROR promotes the progression of renal cell carcinoma through the miR‑206/VEGF axis.
Shi J; Zhang D; Zhong Z; Zhang W
Mol Med Rep; 2019 Oct; 20(4):3782-3792. PubMed ID: 31485634
[TBL] [Abstract][Full Text] [Related]
11. Silencing of tumor-suppressive NR_023387 in renal cell carcinoma via promoter hypermethylation and HNF4A deficiency.
Zhou H; Guo L; Yao W; Shi R; Yu G; Xu H; Ye Z
J Cell Physiol; 2020 Mar; 235(3):2113-2128. PubMed ID: 31432508
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA TUG1 promotes cell proliferation and migration of renal cell carcinoma via regulation of YAP.
Liu S; Yang Y; Wang W; Pan X
J Cell Biochem; 2018 Dec; 119(12):9694-9706. PubMed ID: 30132963
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.
Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J
J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA HOTAIR promotes renal cell carcinoma malignancy through alpha-2, 8-sialyltransferase 4 by sponging microRNA-124.
Pan Y; Wu Y; Hu J; Shan Y; Ma J; Ma H; Qi X; Jia L
Cell Prolif; 2018 Dec; 51(6):e12507. PubMed ID: 30105850
[TBL] [Abstract][Full Text] [Related]
15. Overexpressed lncRNA FTX promotes the cell viability, proliferation, migration and invasion of renal cell carcinoma via FTX/miR‑4429/UBE2C axis.
Chen Z; Zhang M; Lu Y; Ding T; Liu Z; Liu Y; Zhou Z; Wang L
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35866591
[TBL] [Abstract][Full Text] [Related]
16. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
[TBL] [Abstract][Full Text] [Related]
17. LncRNA POU3F3 Promotes Cancer Cell Proliferation, Migration, and Invasion in Renal Cell Carcinoma by Downregulating LncRNA GAS5.
Zhang L; Wang C; Ma M
Kidney Blood Press Res; 2021; 46(5):613-619. PubMed ID: 34352801
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA MEG3 is a tumor suppressor in choriocarcinoma by upregulation of microRNA-211.
Ji L; Li X
J Cell Physiol; 2019 Dec; 234(12):22911-22920. PubMed ID: 31124134
[TBL] [Abstract][Full Text] [Related]
19. lncRNA MEG3 Suppresses the Tumorigenesis of Hemangioma by Sponging miR-494 and Regulating PTEN/ PI3K/AKT Pathway.
Dai Y; Wan Y; Qiu M; Wang S; Pan C; Wang Y; Ou J
Cell Physiol Biochem; 2018; 51(6):2872-2886. PubMed ID: 30562741
[TBL] [Abstract][Full Text] [Related]
20. LncRNA ST3Gal6-AS1/ST3Gal6 axis mediates colorectal cancer progression by regulating α-2,3 sialylation via PI3K/Akt signaling.
Hu J; Shan Y; Ma J; Pan Y; Zhou H; Jiang L; Jia L
Int J Cancer; 2019 Jul; 145(2):450-460. PubMed ID: 30613961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]